69 related articles for article (PubMed ID: 19898186)
1. Intravitreal alemtuzumab penetrates full-thickness retina in rabbit eyes.
Ekdawi NS; Pulido JS; Itty S; Marler RJ; Herman DC; Hardwig P; Mohney BG; Valyi-Nagy T; Shukla D
Retina; 2009; 29(10):1532-4. PubMed ID: 19898186
[TBL] [Abstract][Full Text] [Related]
2. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control.
Pulido JS; Bakri SJ; Valyi-Nagy T; Shukla D
Retina; 2007 Oct; 27(8):1071-3. PubMed ID: 18040247
[TBL] [Abstract][Full Text] [Related]
3. Penetration of bevacizumab through the retina after intravitreal injection in the monkey.
Heiduschka P; Fietz H; Hofmeister S; Schultheiss S; Mack AF; Peters S; Ziemssen F; Niggemann B; Julien S; Bartz-Schmidt KU; Schraermeyer U;
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2814-23. PubMed ID: 17525217
[TBL] [Abstract][Full Text] [Related]
4. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.
Goldenberg DT; Giblin FJ; Cheng M; Chintala SK; Trese MT; Drenser KA; Ruby AJ
Retina; 2011 Feb; 31(2):393-400. PubMed ID: 21099453
[TBL] [Abstract][Full Text] [Related]
5. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model.
Bakri SJ; Cameron JD; McCannel CA; Pulido JS; Marler RJ
Am J Ophthalmol; 2006 Jul; 142(1):162-4. PubMed ID: 16815270
[TBL] [Abstract][Full Text] [Related]
6. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.
Inan UU; Avci B; Kusbeci T; Kaderli B; Avci R; Temel SG
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1773-81. PubMed ID: 17389511
[TBL] [Abstract][Full Text] [Related]
7. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model.
Bakri SJ; Pulido JS; Mukherjee P; Marler RJ; Mukhopadhyay D
Retina; 2008 Jan; 28(1):147-9. PubMed ID: 18185152
[TBL] [Abstract][Full Text] [Related]
8. Safety of intravitreal bevacizumab in the developing rabbit retina.
Zayit-Soudry S; Zemel E; Barak A; Perlman I; Loewenstein A
Retina; 2011 Oct; 31(9):1885-95. PubMed ID: 21799464
[TBL] [Abstract][Full Text] [Related]
9. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A
Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418
[TBL] [Abstract][Full Text] [Related]
10. Subretinal bevacizumab detection after intravitreous injection in rabbits.
Dib E; Maia M; Longo-Maugeri IM; Martins MC; Mussalem JS; Squaiella CC; Penha FM; Magalhães O; Rodrigues EB; Farah ME
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1097-100. PubMed ID: 18326736
[TBL] [Abstract][Full Text] [Related]
11. Long-term tolerability and serum concentration of bevacizumab (avastin) when injected in newborn rabbit eyes.
Wu WC; Lai CC; Chen KJ; Chen TL; Wang NK; Hwang YS; Yeung L; Li LM
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3701-8. PubMed ID: 20181842
[TBL] [Abstract][Full Text] [Related]
12. Safety of intravitreal injection of bevacizumab in rabbit eyes.
Feiner L; Barr EE; Shui YB; Holekamp NM; Brantley MA
Retina; 2006 Oct; 26(8):882-8. PubMed ID: 17031287
[TBL] [Abstract][Full Text] [Related]
13. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
14. Intraocular use of rituximab.
Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits.
Gaudreault J; Fei D; Beyer JC; Ryan A; Rangell L; Shiu V; Damico LA
Retina; 2007; 27(9):1260-6. PubMed ID: 18046235
[TBL] [Abstract][Full Text] [Related]
16. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes.
Albini TA; Abd-El-Barr MM; Carvounis PE; Iyer MN; Lakhanpal RR; Pennesi ME; Chevez-Barrios P; Wu SM; Holz ER
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):390-5. PubMed ID: 17197559
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab (avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice.
Heiduschka P; Julien S; Hofmeister S; Bartz-Schmidt KU; Schraermeyer U
Retina; 2008 Jan; 28(1):46-55. PubMed ID: 18185137
[TBL] [Abstract][Full Text] [Related]
18. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
Bakri SJ; Snyder MR; Reid JM; Pulido JS; Ezzat MK; Singh RJ
Ophthalmology; 2007 Dec; 114(12):2179-82. PubMed ID: 18054637
[TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of repeated intravitreal injections of bevacizumab and ranibizumab in rabbit eyes.
Zayit-Soudry S; Zemel E; Loewenstein A; Perlman I
Retina; 2010 Apr; 30(4):671-81. PubMed ID: 19952984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
